# TARGETED CLINICAL RESEARCH TO ADDRESS SELECT VIRAL INFECTIONS

> **NIH NIH N01** · FRED HUTCHINSON CANCER CENTER · 2022 · $1,120,409

## Abstract

To advance the development of therapeutic strategies for rare and/or emerging viral diseases of medical importance in targeted patient populations by 1) characterizing contemporary course of the clinical disease, and/or 2) directly evaluating a therapy. This study is conducted in adult transplant patients.

## Key facts

- **NIH application ID:** 10576258
- **Project number:** 272201600015C-P00009-9999-1
- **Recipient organization:** FRED HUTCHINSON CANCER CENTER
- **Principal Investigator:** MICHAEL BOECKH
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $1,120,409
- **Award type:** —
- **Project period:** 2016-07-01 → 2023-08-15

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10576258

## Citation

> US National Institutes of Health, RePORTER application 10576258, TARGETED CLINICAL RESEARCH TO ADDRESS SELECT VIRAL INFECTIONS (272201600015C-P00009-9999-1). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/10576258. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*